TSSC1 Antibody

What is TSSC1 and what are its key structural features?

TSSC1, also known as tumor-suppressing subtransferable candidate 1, is a 387 amino acid protein characterized by five WD repeat domains, which are crucial for mediating protein-protein interactions. The protein is widely expressed in various tissues, highlighting its potential role in fundamental cellular processes . Initially reported as a tumor-suppressing fragment in the imprinted gene domain of 11p15.5, genomic sequence analysis later suggested that this gene actually resides on chromosome 2 rather than chromosome 11 . TSSC1 is also known by several protein aliases including EARP and GARP complex-interacting protein 1, Endosome-associated recycling protein-interacting protein, and Golgi-associated retrograde protein-interacting protein . The gene also has aliases including EIPR1 .

What types of TSSC1 antibodies are available for research applications?

Researchers have access to multiple types of TSSC1 antibodies suitable for different experimental approaches:

• Polyclonal antibodies: These include rabbit polyclonal antibodies that recognize specific immunogen sequences such as "VILSNMVSIS SEPFGHLVDD DDISDQEDHR SEEKSKEPLQ DNVIATYEEH EDSVYAVDWS SADPWLFASL SYDGRLVINR VPRALKYH" .

• Monoclonal antibodies: Mouse monoclonal IgG2a kappa light chain antibodies (such as C-7) that detect TSSC1 protein of human origin .

• Conjugated antibodies: TSSC1 antibodies are available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates for specialized applications .

What are the validated applications for TSSC1 antibodies?

TSSC1 antibodies have been validated for multiple experimental applications including:

• Western blotting (WB)

• Immunoprecipitation (IP)

• Immunofluorescence (IF)

• Immunohistochemistry (IHC)

• Enzyme-linked immunosorbent assay (ELISA)

Different antibodies may have specific recommended dilutions. For example, some antibodies are recommended at 0.4 μg/ml for Western Blot and 1:20-1:50 dilution for immunohistochemistry applications .

How should researchers optimize TSSC1 antibody use in Western blotting?

When using TSSC1 antibodies for Western blotting, researchers should consider:

• Sample preparation: Total cell lysates or subcellular fractions (particularly endosomal fractions) may be appropriate depending on experimental goals.

• Loading controls: When studying TSSC1 in relation to endosomal trafficking, appropriate loading controls should be selected based on the cellular compartment being investigated.

• Dilution optimization: Start with the recommended dilution (e.g., 0.4 μg/ml) and optimize as needed.

• Detection method: Both chemiluminescence and fluorescence-based detection systems can be used, with conjugated antibodies (such as HRP-conjugated) offering direct detection options .

• Expected molecular weight: Confirm bands appear at the expected molecular weight for TSSC1.

What considerations are important for immunofluorescence studies using TSSC1 antibodies?

For optimal immunofluorescence results with TSSC1 antibodies:

• Fixation method: Both paraformaldehyde and methanol fixation may be appropriate, but optimization may be required based on epitope accessibility.

• Permeabilization: Since TSSC1 interacts with endosomal membrane complexes, appropriate permeabilization is crucial.

• Co-localization markers: Consider co-staining with markers for:

  • GARP complex components

  • EARP complex components

  • Trans-Golgi network markers

  • Endosomal markers

• Dilution range: Initial testing at dilutions of 1:20-1:50 is recommended for paraffin-embedded samples .

• Advanced imaging: Confocal microscopy is particularly valuable for assessing co-localization of TSSC1 with endosomal compartments .

How can researchers validate TSSC1 antibody specificity?

To ensure experimental validity, researchers should consider these approaches for antibody validation:

• Positive and negative controls: Use tissues or cell lines with known TSSC1 expression levels.

• Knockdown verification: Test antibody specificity in TSSC1-silenced cells or knockout models.

• Peptide competition: Pre-incubate the antibody with the immunogenic peptide to confirm specificity.

• Cross-species reactivity: Some TSSC1 antibodies show high sequence identity to mouse (92%) and rat (92%) orthologs, making them useful for comparative studies .

• Protein array validation: Some commercial antibodies have been validated against protein arrays containing the target protein plus numerous non-specific proteins .

How can TSSC1 antibodies be used to study endosomal trafficking pathways?

TSSC1 has been identified as a novel component of the endosomal retrieval machinery, interacting with both GARP and EARP tethering complexes . Researchers can leverage TSSC1 antibodies to:

• Immunoprecipitation studies: Use IP to identify TSSC1 interaction partners in the endosomal trafficking machinery.

• Co-localization analysis: Perform confocal microscopy to assess TSSC1 co-localization with GARP and EARP complexes .

• Functional studies: Combine antibody staining with cargo trafficking assays, such as:

  • Shiga toxin B subunit transport to the TGN

  • Transferrin recycling from endosomes to the plasma membrane

• FRAP experiments: Study the role of TSSC1 in recruitment of GARP to the TGN using fluorescence recovery after photobleaching techniques .

• Affinity purification: Combine with mass spectrometry to identify novel interactors in the endosomal retrieval pathway .

What approaches can be used to study TSSC1's potential role in tumor suppression?

Given TSSC1's historical association with tumor suppression, researchers can employ these approaches:

• Tissue microarray analysis: Use TSSC1 antibodies to assess expression patterns across normal and tumor tissues, particularly in cancers associated with the 11p15.5 region, including:

  • Wilms tumor

  • Rhabdomyosarcoma

  • Adrenocortical carcinoma

  • Lung cancer

  • Ovarian cancer

  • Breast cancer

• Correlation studies: Combine TSSC1 staining with markers of cell cycle regulation and apoptosis to elucidate potential mechanisms of tumor suppression .

• Cell models: Analyze TSSC1 expression and localization in cell lines derived from Beckwith-Wiedemann syndrome or associated malignancies .

• Functional recovery experiments: In models with altered TSSC1 expression, assess whether reintroduction of TSSC1 restores normal cellular phenotypes.

How can researchers integrate TSSC1 antibodies into multi-omics experimental designs?

For comprehensive characterization of TSSC1 biology:

• ChIP-seq integration: Combine TSSC1 protein data with chromatin immunoprecipitation sequencing to identify potential transcriptional regulatory mechanisms.

• Phosphoproteomics: Use TSSC1 antibodies that specifically recognize phosphorylated forms to map activation status in different cellular contexts.

• Spatial proteomics: Employ TSSC1 antibodies in proximity labeling approaches (BioID or APEX) to map the spatial organization of TSSC1-containing complexes.

• Interactome analysis: Use antibodies for immunoprecipitation followed by mass spectrometry to characterize the complete TSSC1 interactome under different cellular conditions.

• Single-cell approaches: Apply TSSC1 antibodies in single-cell protein analysis techniques to assess heterogeneity of expression and localization.

What are common issues when using TSSC1 antibodies for Western blotting?

Researchers may encounter several challenges:

• Multiple bands: This could indicate:

  • Post-translational modifications

  • Splice variants

  • Protein degradation

  • Non-specific binding

• Weak signal: Consider:

  • Increasing antibody concentration

  • Longer incubation times

  • Enhanced detection systems

  • Enrichment of sample by immunoprecipitation prior to Western blotting

  • Using fresh antibody aliquots (avoid freeze-thaw cycles)

• Background issues: Optimize:

  • Blocking conditions (type of blocking agent and duration)

  • Washing steps (number, duration, and buffer composition)

  • Antibody dilution

  • Use highly purified antibody preparations

What considerations are important when analyzing TSSC1 expression in tissue samples?

For optimal tissue analysis:

• Antigen retrieval: Optimize retrieval methods for paraffin-embedded tissues, as TSSC1 epitopes may be sensitive to fixation.

• Endogenous peroxidase quenching: For IHC applications, ensure complete quenching of endogenous peroxidase activity.

• Background reduction: Use appropriate blocking of endogenous biotin or non-specific binding sites.

• Positive control selection: Include tissues with known TSSC1 expression patterns.

• Quantification approaches: Establish consistent scoring systems for TSSC1 expression intensity and subcellular localization.

How can conflicting results between different TSSC1 antibodies be resolved?

When different antibodies yield inconsistent results:

• Epitope mapping: Determine the exact epitopes recognized by each antibody to understand potential differences in detection of modified or interacting forms.

• Validation in knockout/knockdown models: Confirm specificity of each antibody using genetic models with reduced TSSC1 expression.

• Application-specific optimization: An antibody that works well for Western blotting may not be optimal for immunohistochemistry due to conformation differences.

• Independent detection methods: Validate findings using non-antibody methods such as RNA analysis or tagged protein expression.

• Consider post-translational modifications: Some antibodies may preferentially recognize modified forms of TSSC1.

How can TSSC1 antibodies be used to investigate the interplay between endosomal trafficking and disease?

Given TSSC1's role in endosomal retrieval pathways , researchers can:

• Disease models: Apply TSSC1 antibodies to analyze:

  • Cancer cell lines with altered trafficking properties

  • Neurodegenerative disease models with endosomal dysfunction

  • Models of infectious diseases where pathogens hijack endosomal systems

• Therapeutic intervention assessment: Monitor changes in TSSC1 localization and interactions following treatment with:

  • Compounds targeting endosomal trafficking

  • Cancer therapeutics

  • Antimicrobial agents

• Organoid and 3D culture systems: Apply TSSC1 antibodies to more physiologically relevant models of human tissues to assess trafficking in complex cellular organizations.

What techniques can reveal TSSC1's dynamic behavior in living systems?

For capturing TSSC1 dynamics:

• Live-cell imaging approaches: Though antibodies are typically used in fixed samples, researchers can:

  • Use antibody fragments for intracellular tracking

  • Compare fixed-time-point antibody staining with live imaging of fluorescently tagged TSSC1

  • Apply correlative light and electron microscopy (CLEM) with TSSC1 antibodies to connect dynamics to ultrastructure

• Super-resolution microscopy: Apply techniques such as:

  • Stimulated emission depletion (STED) microscopy

  • Photoactivated localization microscopy (PALM)

  • Stochastic optical reconstruction microscopy (STORM)
    to resolve TSSC1 localization at the nanoscale level in relation to endosomal components.

• Proximity-based interaction studies: Use approaches like Förster resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) combined with antibody validation to study TSSC1's transient interactions.

What are the implications of TSSC1's WD repeat domains for experimental design?

TSSC1 contains five WD repeat domains critical for protein-protein interactions , which has implications for research approaches:

• Domain-specific antibodies: Consider using antibodies that recognize specific WD repeat domains to dissect their individual functions.

• Structural studies: Combine antibody epitope mapping with structural prediction to understand how WD domains contribute to TSSC1 function.

• Interaction disruption strategies: Design experiments to test whether specific WD repeats mediate interactions with GARP, EARP, or other partners.

• Evolutionary conservation analysis: Use antibodies with cross-species reactivity to study the conservation of WD domain functions across species.

• Post-translational modification mapping: Investigate how modifications within or adjacent to WD domains affect TSSC1 interactions and function.